Last updated on March 2019

PK and PD Profile of Dance 501 in Healthy Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Brief description of study

This will be a randomized, open-label, active-controlled, single dose crossover study with either three or four treatment periods. Investigational treatment is with Dance 501 Human Insulin Inhalation Solution (Dance 501) and the comparator is Insulin Lispro (Humalog).

Target population will be Non-Diabetic individuals with mild to moderate asthma or chronic obstructive pulmonary disease (COPD) and non-diabetic individuals without underlying lung disease (healthy subjects).

Detailed Study Description

The PK and PD profile of Dance 501 (Human Insulin Inhalation Solution and Inhaler) will be compared to subcutaneous injection of insulin lispro.

Clinical Study Identifier: NCT03307512

Find a site near you

Start Over


Cypress, CA United States
  Connect »